Locally Advanced or Metastatic Medullary Thyroid Cancer

Explore clinical trials studying Locally Advanced or Metastatic Medullary Thyroid Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Locally Advanced or Metastatic Medullary Thyroid Cancer trial results

Completed

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

NCT01298323

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations: Investigational Site Number : 301 St Leonards, New South Wales, Australia

Investigational Site Number 301 St Leonards, Australia

Investigational Site Number 401 Vienna, Austria

Investigational Site Number : 401 Vienna, Austria

View all 66 locations

View Trial Details

Locally Advanced or Metastatic Medullary Thyroid Cancer

Locally Advanced or Metastatic Medullary Thyroid Cancer trial results

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

Related conditions